Scientists have identified a set of biological markers that could significantly improve how gastrointestinal diseases (GIDs) are detected and treated. These conditions include gastric cancer (GC), colorectal cancer (CRC), and inflammatory bowel disease (IBD).

Their findings show that specific gut bacteria and chemical compounds, known as metabolites, are closely linked to each disease. This raises the possibility of diagnosing these conditions earlier and with less invasive methods. Some of these markers may even signal risk across multiple diseases.

AI Reveals Shared Gut Biomarkers Across Diseases

To uncover these patterns, researchers used advanced machine learning and AI-based tools to analyze microbiome and metabolome data from patients with GC, CRC, and IBD. By comparing data across diseases, they discovered that models trained on one condition could often predict markers for another.…